Global cardiovascular risk evaluation in Italy: A cross-sectional survey in general practice

Italian Heart Journal

Volumn 5, Issue 3, 2004, Pages 223-227

  Filippi, Alessandro ^a   Buda, Stefano ^b   Brignoli, Ovidio ^a   Cricelli, Claudio ^a   Esposti, Ezio Degli ^b  

^a Economics and Outcomes Research   (Italy)

^b Local Health Unit   (Italy)

Author keywords

Hypercholesterolemia; Hypertension; Risk factors

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; CHOLESTEROL;

ADULT; AGE; AGED; ARTICLE; BLOOD; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; DRUG EFFECT; EVALUATION; FEMALE; GENERAL PRACTICE; HUMAN; ITALY; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; RISK FACTOR; SEX DIFFERENCE;

ADULT; AGE FACTORS; AGED; ANTIHYPERTENSIVE AGENTS; ANTILIPEMIC AGENTS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CHOLESTEROL; CROSS-SECTIONAL STUDIES; FAMILY PRACTICE; FEMALE; HUMANS; ITALY; MALE; MIDDLE AGED; RISK FACTORS; SEX FACTORS;

EID: 4644254508     PISSN: 1129471X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Wood D, De Backer G, Faergeman O, Graham I, Mancia G, Pyorala K. The prevention of coronary disease in clinical practice. The recommendations of the Second Joint Task Force of European societies on the prevention of coronary pathology. Ital Heart J Suppl 2000; 1: 692-8.
2. McBride PE. Perspectives: the NCEP ATP III guidelines-friend or foe? National Cholesterol Education Program. Prev Cardiol 2002; 5: 152-5.
3. Voss R, Cullen P, Schulte H, Assmann G. Prediction of risk of coronary events in middle-aged men in the Prospective Cardiovascular Munster Study (PROCAM) using neural networks. Int J Epidemiol 2002; 31: 1253-62.
4. Menotti A, Lanti M, Puddu PE, Kromhout D. Coronary heart disease incidence in northern and southern European populations: a reanalysis of the seven countries study for a European coronary risk chart. Heart 2000; 84: 238-44.
5. Menotti A, Puddu PE, Lanti M. Comparison of the Framingham risk function-based coronary chart with risk function from an Italian population study. Eur Heart J 2000; 21: 365-70.
6. Ramsay LE, Williams B, Johnston DG, et al. Guidelines for management of hypertension: report of the Third Working Party of the British Hypertension Society. J Hum Hypertens 1999; 13: 569-92.
7. Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on coronary prevention. Eur Heart J 1998; 19: 1434-503.
8. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997; 157: 2413-46.
9. Guidelines Subcommittee. 1999 World Health Organization-International Society of Hypertension guidelines for the management of hypertension. J Hypertens 1999; 17: 151-83.
10. Hippisley-Cox J, Pringle M. General practice workload implications of the national service framework for coronary heart disease: cross sectional survey. BMJ 2001; 323: 269-70.
11. Toop L, Richards D. Preventing cardiovascular disease in primary care. BMJ 2001; 323: 246-7.
12. EUROASPIRE II Study Group. Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme. Eur Heart J 2001; 22: 554-72.
13. Hall LM, Jung RT, Leese GP. Controlled trial of effect of documented cardiovascular risk scores on prescribing. BMJ 2003; 326: 251-2.